ARSArs Technica·3hHealth
score+0.70
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Original
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
“Highlights significant clinical trial success in reducing cancer mortality and recurrence, framing medical progress positively without hyperbole.”